Estimating the cost of cancer care in the United States: A work very much in progress

Journal of the National Cancer Institute

Volumn 100, Issue 9, 2008, Pages 607-610

  Lipscomb, Joseph ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; EDITORIAL; HEALTH CARE COST; PRIORITY JOURNAL; AGED; BREAST TUMOR; CANCER REGISTRY; COLORECTAL TUMOR; COST OF ILLNESS; ECONOMICS; FEMALE; HUMAN; LUNG TUMOR; MALE; MEDICARE; MORTALITY; NEOPLASM; NOTE; PROSTATE TUMOR; SURVIVAL RATE; UNITED STATES;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; LUNG NEOPLASMS; MALE; MEDICARE; NEOPLASMS; PROSTATIC NEOPLASMS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 44049096610     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn132     Document Type: Editorial

References (14)

1. Lipscomb J, Donaldson M, Hiatt RA. Cancer outcomes research and the arenas of application. J Natl Cancer Inst Monogr. 2004;33(1):1-7.
2. Yabroff KR, Warren JL, Brown ML. Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol. 2007;4(11):643-656.
3. National Cancer Institute. Cancer trends progress report - 2007 update. http://progressreport.cancer.gov. Accessed March 21, 2008.
4. Thorpe KE, Florence CS, Joski P. Which medical conditions account for the rise in health care spending?. Health Aff. (Web exclusive). 2004;W4-437-W4-445. http://content.healthaffairs.org/cgi/reprint/hlthaff.w4. 437v1.pdf. Accessed March 23, 2008.
5. Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100(9):630-641.
6. Brown ML, Riley GF, Schussler N, Etzioni RD. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(8):(suppl)104-117.
7. Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995;87(6):417-426.
8. Baker MS, Kessler LG, Urban N, et al. Estimating the treatment costs of breast and lung cancer. Med Care. 1991;29 (1):40-49.
9. Yabroff KR, Mariotto AB, Feuer E, Brown ML. Projections of the costs associated with colorectal cancer in the United States, 2000-2020 [published online ahead of print October 2, 2007]. Health Econ. www.interscience. wiley.com http://www3.interscience.wiley.com/cgi-bin/fulltext/116325138/ PDFSTART. doi:10.1002/hec.1307.
10. Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, Kuntz KM. Report to the Agency for Healthcare Research and Quality and the Centers for Medicare & Medicaid Services from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models. Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer. Rockville, MD: Agency for Healthcare Research and Quality;2007. http://www.cms.hhs.gov/determinationprocess/downloads/id52TA.pdf. Accessed on March 22, 2008.
11. Thompson D, Taylor DCA, Montoya EL, Winer EP, Jones SE, Weinstein MC. Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancer. Value Health. 2007;10(5):367-376.
12. Ritzwoller DP, Goodman MJ, Maciosek MV, et al. Creating standard cost measures across integrated health care delivery systems. J Natl Cancer Inst Monogr. 2005;35(2):80-87.
13. Howard DH, Molinari N-A, Thorpe KE. National estimates of medical costs incurred by non-elderly cancer patients. Cancer. 2004;100(5):883-891.
14. Yabroff KR, Davis WW, Lamont EB, et al. Patient time costs associated with cancer care. J Natl Cancer Inst. 2007;99(1):14-23.